4th Quarter - Report — CEPI-U.S. for CEPI-U.S. (2025)

Firm

CEPI-U.S.

Client

CEPI-U.S.

Income

—

Expenses

$60,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

Education and advocacy supporting the funding and mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines and other countermeasures for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026, Title III, provisions relating to global health programs and global health security. Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2026, Title III, provisions relating to global health programs and global health security (no bill number available as of filing).

Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines and other countermeasures against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.

Lobbyist	Covered position, as disclosed
DANIEL SKALLMAN	—

Contacted: Overseas Private Investment Corp (OPIC); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Defense, Dept of (DOD); Natl Security Council (NSC); SENATE

Bills named: H.R. 4779 (119th)

Budget/Appropriations BUD

Lobbyist	Covered position, as disclosed
DANIEL SKALLMAN	—

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Natl Security Council (NSC); SENATE

Bills named: H.R. 4779 (119th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

Entity	Country	Principal place of business	Ownership	Contribution declared
COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS	Norway	Norway	100.0%	$60,000

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.